Cover Image

<i>Acinetobacter baumannii</i> Resistance to Sulbactam/Durlobactam: A Systematic Review

Infections caused by carbapenem-resistant <i>Acinetobacter baumannii</i> (CRAB) have limited therapeutic options. Sulbactam-durlobactam is a combination of two βlactamase inhibitors with activity against CRAB under phase 3 clinical investigation. We performed a systematic review on in vi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Luigi Principe (Author), Stefano Di Bella (Author), Jacopo Conti (Author), Mariagrazia Perilli (Author), Alessandra Piccirilli (Author), Cristina Mussini (Author), Giuliana Decorti (Author)
Format:	Book
Published:	MDPI AG, 2022-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

In Vitro Activity of Sulbactam-Durlobactam against Carbapenem-Resistant <i>Acinetobacter baumannii</i> Clinical Isolates: A Multicentre Report from Italy
by: Bernardetta Segatore, et al.
Published: (2022)

Cefiderocol and Sulbactam-Durlobactam against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Arta Karruli, et al.
Published: (2023)

Analysis of Antimicrobial Resistance Genes (ARGs) in Enterobacterales and <i>A. baumannii</i> Clinical Strains Colonizing a Single Italian Patient
by: Alessandra Piccirilli, et al.
Published: (2023)

A New Twist: The Combination of Sulbactam/Avibactam Enhances Sulbactam Activity against Carbapenem-Resistant <i>Acinetobacter baumannii</i> (CRAB) Isolates
by: Fernando Pasteran, et al.
Published: (2021)

Comparing the Outcomes of Cefoperazone/Sulbactam-Based and Non-Cefoperazone/Sulbactam-Based Therapeutic Regimens in Patients with Multiresistant <i>Acinetobacter baumannii</i> Infections-A Meta-Analysis
by: Chienhsiu Huang, et al.
Published: (2024)

Pulmonary Pharmacokinetic and Pharmacodynamic Evaluation of Ampicillin/Sulbactam Regimens for Pneumonia Caused by Various Bacteria, including <i>Acinetobacter baumannii</i>
by: Tetsushu Onita, et al.
Published: (2023)

Evaluation of Fosfomycin-Sulbactam Combination Therapy against Carbapenem-Resistant <i>Acinetobacter baumannii</i> Isolates in a Hollow-Fibre Infection Model
by: Sazlyna Mohd Sazlly Lim, et al.
Published: (2022)

Whole-Genome Sequencing of ST2 <i>A. baumannii</i> Causing Bloodstream Infections in COVID-19 Patients
by: Sabrina Cherubini, et al.
Published: (2022)

Synergistic Activity of Temocillin and Fosfomycin Combination against KPC-Producing <i>Klebsiella pneumoniae</i> Clinical Isolates
by: Venera Costantino, et al.
Published: (2024)

Is It Possible to Eradicate Carbapenem-Resistant <i>Acinetobacter baumannii</i> (CRAB) from Endemic Hospitals?
by: Filippo Medioli, et al.
Published: (2022)

RapidResa Polymyxin <i>Acinetobacter</i> NP<sup>®</sup> Test for Rapid Detection of Polymyxin Resistance in <i>Acinetobacter baumannii</i>
by: Maxime Bouvier, et al.
Published: (2021)

Identification of IncA Plasmid, Harboring <i>bla</i><sub>VIM-1</sub> Gene, in <i>S. enterica</i> Goldcoast ST358 and <i>C. freundii</i> ST62 Isolated in a Hospitalized Patient
by: Alessandra Piccirilli, et al.
Published: (2023)

Efficacy of Cefoperazone Sulbactam in Patients with <i>Acinetobacter</i> Infections: A Systematic Review of the Literature
by: Gowthami Sai Kogilathota Jagirdhar, et al.
Published: (2023)

Colistin Resistance in <i>Acinetobacter baumannii:</i> Molecular Mechanisms and Epidemiology
by: Katarina Novović, et al.
Published: (2023)

Treatment Strategies of Colistin Resistance <i>Acinetobacter baumannii</i> Infections
by: Andria Papazachariou, et al.
Published: (2024)

Pan-Resistome Insights into the Multidrug Resistance of <i>Acinetobacter baumannii</i>
by: Diego Lucas Neres Rodrigues, et al.
Published: (2021)

<i>Acinetobacter baumannii</i> Resistance: A Real Challenge for Clinicians
by: Rosalino Vázquez-López, et al.
Published: (2020)

Comparative Metabolomics Reveals Key Pathways Associated With the Synergistic Killing of Colistin and Sulbactam Combination Against Multidrug-Resistant Acinetobacter baumannii
by: Mei-Ling Han, et al.
Published: (2019)

Expression analysis of drug-resistant gene (blaOXA-51) in carbapenemases producing Acinetobacter baumannii treated with imipenem/sulbactam combination
by: Saber Noshadi, et al.
Published: (2021)

In Vitro Antimicrobial Activity of the Siderophore Cephalosporin Cefiderocol against <i>Acinetobacter baumannii</i> Strains Recovered from Clinical Samples
by: Davide Carcione, et al.
Published: (2021)

Combined PK/PD Index May Be a More Appropriate PK/PD Index for Cefoperazone/Sulbactam against <i>Acinetobacter baumannii</i> in Patients with Hospital-Acquired Pneumonia
by: Yingjie Zhou, et al.
Published: (2022)

Antibiotic Resistance and Genotypes of Nosocomial Strains of <i>Acinetobacter baumannii</i> in Kazakhstan
by: Alyona Lavrinenko, et al.
Published: (2021)

Biofilm-Induced Antibiotic Resistance in Clinical <i>Acinetobacter baumannii</i> Isolates
by: Abebe Mekuria Shenkutie, et al.
Published: (2020)

<it>In vitro </it>activity of tigecycline in combination with various antimicrobials against multidrug resistant <it>Acinetobacter baumannii</it>
by: Petrosillo Nicola, et al.
Published: (2009)

An <i>Acinetobacter</i> non-<i>baumannii</i> Population Study: Antimicrobial Resistance Genes (ARGs)
by: Adam Baraka, et al.
Published: (2020)

Quercetin: Synergistic Interaction with Antibiotics against Colistin-Resistant <i>Acinetobacter baumannii</i>
by: Elif Odabaş Köse, et al.
Published: (2023)

Systematic Review of Antimicrobial Combination Options for Pandrug-Resistant <i>Acinetobacter baumannii</i>
by: Stamatis Karakonstantis, et al.
Published: (2021)

Characterization of Extremely Drug-Resistant and Hypervirulent <i>Acinetobacter baumannii</i> AB030
by: Manu Singh, et al.
Published: (2020)

Isolation and Characterization of Novel Bacteriophages to Target Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Yoon-Jung Choi, et al.
Published: (2024)

CRISPR-Based Gene Editing in <i>Acinetobacter baumannii</i> to Combat Antimicrobial Resistance
by: Muhammad Junaid, et al.
Published: (2023)

Characterization of Increased Extracellular Vesicle-Mediated Tigecycline Resistance in <i>Acinetobacter baumannii</i>
by: Hyejin Cho, et al.
Published: (2023)

Novel Antimicrobial Peptide "Octoprohibitin" against Multidrug Resistant <i>Acinetobacter baumannii</i>
by: E. H. T. Thulshan Jayathilaka, et al.
Published: (2022)

In Vitro and In Vivo Activity of AS101 against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Tsung-Ying Yang, et al.
Published: (2021)

A Randomized Controlled Trial of Colistin Combined with Sulbactam: 9 g per Day versus 12 g per Day in the Treatment of Extensively Drug-Resistant <i>Acinetobacter baumannii</i> Pneumonia: An Interim Analysis
by: Chutchawan Ungthammakhun, et al.
Published: (2022)

<i>Acinetobacter baumannii</i> Infections in Hospitalized Patients, Treatment Outcomes
by: Diaa Alrahmany, et al.
Published: (2021)

DksA Modulates Antimicrobial Susceptibility of <i>Acinetobacter baumannii</i>
by: Nayeong Kim, et al.
Published: (2021)

Investigating Bacteriophages Targeting the Opportunistic Pathogen <i>Acinetobacter baumannii</i>
by: Kathryn M. Styles, et al.
Published: (2020)

Prosthetic valve endocarditis caused by <i> Acinetobacter baumannii </i> complex
by: Kumar S, et al.
Published: (2008)

Comparison in a rat thigh abscess model of imipenem, meropenem and cefoperazone-sulbactam against <it>Acinetobacter baumannii </it>strains in terms of bactericidal efficacy and resistance selection
by: Gundes Sibel, et al.
Published: (2004)

Antimicrobial Resistance Determinants in Genomes and Plasmids from <i>Acinetobacter baumannii</i> Clinical Isolates
by: Itziar Chapartegui-González, et al.
Published: (2021)